Abstract
Introduction

Hepatocellular carcinoma (HCC) is a common malignancy in Japan and the diagnosis and treatment of HCC has progressed (1). Although curative treatment is available and the survival of patients with an early stage of HCC increases, curative treatment is difficult and the prognosis is poor at advanced stage of HCC. Even in the patients with advanced stage HCC, intraperitoneal dissemination of HCC is rare (2). Ruptured HCC increases the risk of abdominal dissemination and the prognosis of patients with ruptured HCC is usually worse than that of non-ruptured HCC
. Thus, abdominal dissemination of HCC is considered in a terminal stage (2) .
Vitamin K2 is known to inhibit the growth of a variety of tumor cell lines by inducing apoptosis or differentiation (5, 6) . Vitamin K2 was recently used for the treatment of several human cancers including myelodysplastic syndrome (5) . Vitamin E is also known to be an apoptotic agent for tumor cells and prevents hepatocarcinogenesis in animal models (7, 8) . It is reported that administration of vitamin E for patients with liver cirrhosis and hepatitis C virus (HCV) infection resulted in a lower rate of development of HCC and a higher cumulative survival without development of HCC (8) .
In this report, we present a case of regression of perito
F i g u r e 1 . De mo n s t r a t i o n o f h e p a t o c e l l u l a r c a r c i n o ma ( HCC) b y e n h a n c e d c o mp u t e d t o mo g r ap h y ( CT ) . A: CT s h o ws a HCC me a s u r i n g 3 c m i n d i a me t e r a t s e g me n t 4 o f t h e l i v e r ( a r r o w) a n d h i g h -d e n s i t y a s c i t e s ( a r r o wh e a d ) . B : CT s h o ws a HCC wi t h l i p i o d o l d e p o s i t i o n ( a r r o w) a n d a l a r g e a mo u n t o f a s c i t e s s o o n a f t e r t h e o p e r a t i o n . C: CT s h o ws a HCC wi t h l i p i o d o l d e p o s i t i o n ( a r r o w) a n d d e c r e a s e d a s c i t e s 6 mo n t h s a f t e r t h e a d mi n i s t r a t i o n o f v i t a mi n s K2 a n d E ( C) . T h e s i z e o f t h e HCC d i d n o t c h
a n g e i n 6 mo n t h s . (Fig. 3B) . Surgical treatment was aborted. Soon after the operation, CT demonstrated HCC measuring 3 cm in diameter at segment 4 (Fig. 1B) , disseminated tumors and ascites in the abdominal cavity (Fig. 4A, B) (Fig. 5) , and HCC in segment 4 did not increase in size (Fig. 1C) , ascites did not increase and disseminated tumors disappeared on CT (Fig. 4C, D) . During the six months, the PIVKA-II level was within normal range.
. He p a t i c a r t e r i o g r a p h y s h o ws a t u mo r s t a i n ( a r r o w) . A: E a r l y p h a s e . B : L a t e p h a s e .
F i g u r e 3 . P a t h o l o g i c a l f e a t u r e s o f d i s s e mi n a t e d t u mo r i n t h e o me n t u m a t o p e r a t i o n . A: Ma c r o -
Discussion
Although the recent improvements of the treatment for HCC such as operation and radiofrequency ablation are remarkable, a treatment for peritoneal dissemination of HCC has not been established (9) (16) (17) (18) . The case of recurrent HCC with peritoneal dissemination and splenic metastasis which disappeared after administration of UFT was reported (19) . In the present case, TAE was repeatedly performed for primary HCC but the peritoneal dissemination was difficult to treat because of the poor clinical condition even though the peritoneal dissemination was detected before surgery. (20) . PKA itself induces cell cycle arrest and activates downstream transcriptional factors, activating enhancer-binding protein-2 and upstream transcription factor-1, which are related to growth inhibition (20) . Furthermore, Wang et al reported that vitamin K2 induced c-myc resulted in apoptosis of hepatoma cells (21) . Clinically, vitamin K2 is known to be used in the treatment of myelodysplastic syndrome (22) . As for HCC, administration of vitamin K2 prevents the development of HCC in women with viral cirrhosis and that suppresses the recurrence of HCC and improves survival in patients who have received curative treatment of HCC (6, 22) .
. In patients with extrahepatic metastases of HCC, most patients with bone metastases died from hepatic cause but approximately one-third of the patients with metastases other than bone died from extrahepatic causes (10). Therefore, it is important to treat extrahepatic HCC including peritoneal dissemination in order to improve survival and provide a good quality of life even when the patient is in the terminal stage of HCC. It is usually difficult to completely resect peritoneal dissemination of HCC (2, 11). However, repeated resection for peritoneal dissemination of HCC could contribute to the long-term survival (3, 12). Radiotherapy is used either in combination with or as an alternative to surgery (13). For example, the patient with HCC underwent six repeated resections and two radiotherapy for peritoneal dissemination, and the patient remained alive without any evidence of recurrence for three years (14). Hyperthermia could be considered as one of the multimodal treatments (11). Reportedly, the combination of transarterial chemoembolization and hyperthermia was effective against peritoneal HCC in an animal experiment (15). A variety of systemic chemotherapy have been tested in HCC, including combination therapies with cisplatin, doxorubicin and tegafur and uracil (UFT), and alpha-interferon and UFT
Vitamin K2 is known to inhibit the growth and invasion of HCC cell lines in vitro (20, 21). Moreover, administration of vitamin K2 to nude mice implanted liver tumor cells inhibited the growth of the liver tumor (20). Although the mechanisms associated with the antiproliferative effects of
F i g u r e 4 . Di s s e mi n a t e d t u mo r s a n d a s c i t e s b y e n h a n c e d CT . A, B : A f e w d i s s e mi n a t e d t u mo r s ( a r r o ws ) a n d l a r g e a mo u n t o f a s c i t e s a r e f o u n d s o o n a f t e r t h e o p e r a t i o n . C, D: T h e r e i s n o d i s s e mi n a t e d t u mo r a n d o n l y a s ma l l a mo u n t o f a s c i t e s a t 6 mo n t h s a f t e r s t a r t o f a d mi n i s t r a t i o n o f v i t a mi n s K2 a n d E .
F i g u r e 5 . Cl i n i c a l c o u r s e o f t h e p a t i e n t . vitamin K2 against tumor cells remain unknown, it has been proposed that the effect of vitamin K2 may occur through activation of protein kinase A (PKA) pathway
Vitamin E is known to induce apoptotic cell death in various cell types in vitro and to inhibit tumorigenesis in vivo (7, 23, 24 (6) . Vitamin E was also used for chemoprevention of HCC using the same dosage for the treatment of peripheral nerve impediment and there were no adverse effects (8) 
